dr. hart on antibody-drug conjugates in her2 breast cancer
Published 4 years ago • 666 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:03
dr. hart on personalized treatment approach for patients with her2 breast cancer
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
0:57
dr. cobleigh on antibody-drug conjugates in development in her2 breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
37:44
clinical perspectives on her2-targeted antibody-drug conjugates: treatment-related adverse events
-
2:00
antibody drug conjugates / adcs - alessandra storm mauricio | breakthrough junior challenge 2024
-
1:29:14
optimal implementation of antibody-drug conjugates
-
4:18
antibody conjugates: what you need to know | cst tech tips
-
3:42
antibody drug conjugates in metastatic breast cancer | anthony elias, md | esmo22 colorado
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
11:25
podcast 293: her2-“low” breast cancer and its reponse to an antibody-drug conjugate
-
2:40
emergence of antibody-drug conjugates in metastatic breast cancer: 2022 esmo florida
-
18:25
emerging antibody-drug conjugates in breast cancer: an expert analysis of promising therapies
-
5:59
use of antibody drug conjugates and potential for ild
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
0:49
optimizing patient selection for antibody drug conjugates in breast cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
8:12
role of antibody drug conjugates and personal experience
-
1:45
antibody drug conjugates in metastatic breast cancer | sramila aithal, md | esmo22 pennsylvania